In vitro and in vivo efficacy of Molnupiravir against Zika virus infections

Zhuang Wang, Shaokang Yang, Qingsong Dai, Xiaojia Guo, Yuexiang Li, Wei Li, Xiaotong Yang, Jingjing Yang, Xintong Yan, Huimin Tao, Chongda Luo, Song Li, Xingjuan Chen, Ruiyuan Cao, Wu ZhongVirologica 2023 · DOI · OpenAlex

Abstract

• Molnupiravir exhibits effective antiviral activity against ZIKV in vitro. • Intraperitoneal administration of Molnupiravir protects mice from lethal ZIKV challenge. • Molnupiravir might act on the replication phase of the ZIKV life cycle.
BibTeX
@inproceedings{wang2023vitro,
  author = {Zhuang Wang and Shaokang Yang and Qingsong Dai and Xiaojia Guo and Yuexiang Li and Wei Li and Xiaotong Yang and Jingjing Yang and Xintong Yan and Huimin Tao and Chongda Luo and Song Li and Xingjuan Chen and Ruiyuan Cao and Wu Zhong},
  title = {{In vitro and in vivo efficacy of Molnupiravir against Zika virus infections}},
  booktitle = {Virologica},
  year = {2023},
  doi = {10.1016/j.virs.2023.05.011},
}

Loading related content...

Figure